Written by Kenmont Group

AuriPro™ Reduces Infections in Pediatric Patients Undergoing Ear Tube Placement Surgery

The last thing that a parent wants to hear after a child undergoes ear tube surgery, is that the child still has an ear infection. AuriPro is a new formulation of the antibiotic ciprofloxacin that forms a gel inside the middle ear. Placed by the ear, nose and throat specialist at the time of myringotomy and ear tube surgery, the antibiotic remains in the middle ear for one week, and contains the same dose as a one week course of twice-daily ear drops.  Two placebo-controlled, randomized clinical trials demonstrated that AuriPro reduces postoperative ear drainage by 50% in the first month after tube surgery.

Carl LeBel, Ph.D., Chief Medical Officer of Otonomy, Inc., presented the results at a clinical investigator’s meeting in Orlando Florida, September 21, 2014, in conjunction with the annual meeting of the American Academy of Otolaryngology-Head and Neck Surgery.

Dr. Armstrong and Richmond ENT are proud to have been a study site for the development of this new product.

For more information, visit: www.otonomy.com